Acute psilocybin enhances cognitive flexibility in rats.

Area of Science:

• Neuroscience
• Pharmacology
• Behavioral Science

Background:

• Psilocybin shows promise in treating depression and anxiety, often with psychotherapy.
• Understanding the neural mechanisms behind psilocybin's clinical efficacy requires novel experimental approaches.
• A potential mechanism is psilocybin's enhancement of cognitive flexibility.

Approach:

• Investigated psilocybin's effect on cognitive flexibility in male and female rats.
• Utilized a task measuring the ability to switch between learned strategies in response to environmental changes.
• Examined the role of serotonin receptors (5HT2A, 5HT2C) and another psychedelic (DOI) in mediating these effects.

Key Points:

• Acute psilocybin administration significantly improved cognitive flexibility in rats.
• This effect was selective for strategy switching and did not impact Pavlovian reversal learning.
• The serotonin 5HT2A receptor antagonist ketanserin blocked psilocybin's effect, while a 5HT2C antagonist did not.
• Ketanserin alone also enhanced set-shifting, indicating a complex pharmacological interaction.
• The psychedelic DOI impaired cognitive flexibility, showing the effect is not universal among serotonergic psychedelics.

Conclusions:

• Acute psilocybin enhances cognitive flexibility via the serotonin 5HT2A receptor.
• This provides a valuable animal model for studying the neurobiological underpinnings of psilocybin's therapeutic benefits.
• The findings highlight a specific cognitive mechanism potentially contributing to psilocybin's clinical success in mental health treatment.